Oncology Hematology West — Omaha, Nebraska

Oncology Hematology West is a clinical research site located in Omaha, Nebraska, United States 68124.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Oncology Hematology West has participated in 15 clinical trials with 2 currently active.

Therapeutic areas: Adenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer.

Sponsors: SWOG Cancer Research Network, Eli Lilly and Company, Genmab.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology West?

Oncology Hematology West has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology West conducted?

Oncology Hematology West has 15 clinical trials on record, with 2 currently active. Their work covers Adenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer.

Is Oncology Hematology West accredited by Crixeo Clinical Trials?

Oncology Hematology West has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology West?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.